Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo After Hindlimb Ischemia

Hindlimb ischemia is an unmet medical need, especially for those patients unable to undergo vascular surgery. Cellular therapy, mainly through mesenchymal stromal cell (MSC) administration, may be a potentially attractive approach in this setting. In the current work, we aimed to assess the potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibáñez-Fonseca, Arturo, Rico, Ana, Preciado, Silvia, González-Pérez, Fernando, Muntión, Sandra, García-Briñón, Jesús, García-Macías, María-Carmen, Rodríguez-Cabello, José Carlos, Pericacho, Miguel, Alonso, Matilde, Sánchez-Guijo, Fermín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260019/
https://www.ncbi.nlm.nih.gov/pubmed/35814011
http://dx.doi.org/10.3389/fbioe.2022.918602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260019/
https://www.ncbi.nlm.nih.gov/pubmed/35814011
http://dx.doi.org/10.3389/fbioe.2022.918602

Ejemplares similares